2013 13G INITIAL ANNUAL FILING - BRMN

Company

BIOMARIN PHARMACEUTICAL INC

Filed

February 6, 2014

Accession Number

0000053417-14-000012

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →